facebook
Subscribe50$/product give away!


Submit an Article to Pharmacy HQ     
Please include the author's name, title, and citations.     

ALOGLIPTIN AND PIOGLITAZONE- alogliptin benzoate and pioglitazone hydrochloride tablet, film coated


  1. Patient Information
  2. Heart Failure:
  3. Before You Start Taking Alogliptin And Pioglitazone Tablets:
  4. Call Your Doctor Right Away If You Have Any Of The Following Symptoms:
  5. Inflammation Of The Pancreas (pancreatitis):
  6. Tell Your Doctor If You Have Ever Had:
  7. What Are Alogliptin And Pioglitazone Tablets?
  8. Do Not Take Alogliptin And Pioglitazone Tablets If You:
  9. Before You Start Taking Alogliptin And Pioglitazone Tablets, Tell Your Doctor If You:
  10. How Should I Take Alogliptin And Pioglitazone Tablets?
  11. Alogliptin And Pioglitazone Tablets Can Cause Serious Side Effects, Including:
  12. Active Ingredients:
  13. Inactive Ingredients:

Patient Information 

Advise the patient to read the FDA-approved patient labeling (Medication Guide).

Inform patients of the potential risks and benefits of alogliptin and pioglitazone tablets.

Patients should be informed of the signs and symptoms of heart failure. Patients who experience an unusually rapid increase in weight or edema or who develop shortness of breath or other symptoms of heart failure while on alogliptin and pioglitazone tablets should immediately report these symptoms to their physician. Before initiating alogliptin and pioglitazone tablets, patients should be asked about a history of heart failure or other risk factors for heart failure including moderate to severe renal impairment.

Patients should be informed that acute pancreatitis has been reported during use of alogliptin. Patients should be informed that persistent, severe abdominal pain, sometimes radiating to the back, which may or may not be accompanied by vomiting, is the hallmark symptom of acute pancreatitis. Patients should be instructed to promptly discontinue alogliptin and pioglitazone tablets and contact their physician if persistent severe abdominal pain occurs.

Patients should be informed that allergic reactions have been reported during use of alogliptin and pioglitazone. If symptoms of allergic reactions (including skin rash, hives and swelling of the face, lips, tongue and throat that may cause difficulty in breathing or swallowing) occur, patients should be instructed to discontinue alogliptin and pioglitazone tablets and seek medical advice promptly.

Patients should be informed that postmarketing reports of liver injury, sometimes fatal, have been reported during use of alogliptin and pioglitazone. If signs or symptoms of liver injury occur (e.g., unexplained nausea, vomiting, abdominal pain, fatigue, anorexia or dark urine), patients should be instructed to discontinue alogliptin and pioglitazone tablets and seek medical advice promptly.

Tell patients to promptly report any sign of macroscopic hematuria or other symptoms such as dysuria or urinary urgency that develop or increase during treatment, as these may be due to bladder cancer.

Inform patients that hypoglycemia can occur, particularly when an insulin secretagogue or insulin is used in combination with alogliptin and pioglitazone tablets. Explain the risks, symptoms and appropriate management of hypoglycemia.

Inform female patients that treatment with pioglitazone, like other thiazolidinediones, may result in an unintended pregnancy in some premenopausal anovulatory females due to its effect on ovulation[seeUse in Specific Populations (8.3)].

Inform patients that severe and disabling joint pain may occur with this class of drugs. The time to onset of symptoms can range from one day to years. Instruct patients to seek medical advice if severe joint pain occurs.

Inform patients that bullous pemphigoid may occur with this class of drugs. Instruct patients to seek medical advice if blisters or erosions occur[seeWarnings and Precautions (5.11)].

Instruct patients to take alogliptin and pioglitazone tablets only as prescribed daily. Alogliptin and pioglitazone tablets can be taken with or without meals. If a dose is missed, advise patients not to double their next dose.

Patients should be informed that the tablets must never be split.

Instruct patients to read the Medication Guide before starting alogliptin and pioglitazone tablets therapy and to reread each time the prescription is refilled. Instruct patients to inform their healthcare provider if an unusual symptom develops or if a symptom persists or worsens.

ALS333 R5

Heart Failure: 

Alogliptin and pioglitazone tablets can cause heart failure and cause your body to keep extra fluid (fluid retention), which leads to swelling (edema) and weight gain. Extra body fluid can make some heart problems worse or lead to heart failure.

Before You Start Taking Alogliptin And Pioglitazone Tablets: 

Tell your doctor if you have ever had heart failure or have problems with your kidneys.

Call Your Doctor Right Away If You Have Any Of The Following Symptoms: 

  • shortness of breath or trouble breathing, especially when you lie down
  • an unusually fast increase in weight
  • swelling or fluid retention, especially in the feet, ankles, or legs

These may be symptoms of heart failure.

2.

Inflammation Of The Pancreas (pancreatitis): 

Alogliptin, one of the medicines in alogliptin and pioglitazone tablets, may cause pancreatitis, which may be severe. Certain medical conditions make you more likely to get pancreatitis.

Tell Your Doctor If You Have Ever Had: 

  • pancreatitis
  • kidney problems
  • liver problems

Stop taking alogliptin and pioglitazone tablets and call your doctor right away if you have pain in your stomach area (abdomen) that is severe and will not go away. The pain may be felt going from your abdomen through to your back. The pain may happen with or without vomiting. These may be symptoms of pancreatitis.

What Are Alogliptin And Pioglitazone Tablets? 

  • Alogliptin and pioglitazone tablets contain 2 prescription diabetes medicines, alogliptin (NESINA) and pioglitazone (ACTOS).
  • Alogliptin and pioglitazone tablets are a prescription medicine used along with diet and exercise to improve blood sugar (glucose) control in adults with type 2 diabetes.
  • Alogliptin and pioglitazone tablets are not for people with type 1 diabetes.
  • Alogliptin and pioglitazone tablets are not for people with diabetic ketoacidosis (increased ketones in blood or urine).

It is not known if alogliptin and pioglitazone tablets are safe and effective in children under the age of 18. Alogliptin and pioglitazone tablets are not recommended for use in children.

Do Not Take Alogliptin And Pioglitazone Tablets If You: 

  • have severe heart failure
  • are allergic to alogliptin (NESINA), pioglitazone (ACTOS) or any ingredient in alogliptin and pioglitazone tablets or have had a serious allergic (hypersensitivity) reaction to alogliptin or pioglitazone.

Before You Start Taking Alogliptin And Pioglitazone Tablets, Tell Your Doctor If You: 

  • have heart failure
  • have a type of diabetic eye disease that causes swelling of the back of the eye (macular edema)
  • have kidney or liver problems
  • have or have had inflammation of the pancreas (pancreatitis)
  • have or have had cancer of the bladder
  • have other medical conditions
  • are pregnant or plan to become pregnant.It is not known if alogliptin and pioglitazone tablets can harm your unborn baby. Talk to your doctor about the best way to control your blood sugar while you are pregnant or if you plan to become pregnant.
  • are a premenopausal woman who does not have periods regularly or at all.Alogliptin and pioglitazone tablets may increase your chance of becoming pregnant. Talk to your doctor about birth control choices while taking alogliptin and pioglitazone tablets. Tell your doctor right away if you become pregnant while taking alogliptin and pioglitazone tablets.
  • are breastfeeding or plan to breastfeed.It is not known whether alogliptin and pioglitazone pass into your breast milk and if it can harm your baby. Talk with your doctor about the best way to control your blood glucose levels while breastfeeding.

Tell your doctor about all the medicines you take,including prescription and over-the-counter medicines, vitamins and herbal supplements.

Know the medicines you take. Keep a list of them and show it to your doctor and pharmacist before you start a new medicine.

Alogliptin and pioglitazone tablets may affect the way other medicines work, and other medicines may affect how alogliptin and pioglitazone tablets work. Contact your doctor before you start or stop other types of medicines.

How Should I Take Alogliptin And Pioglitazone Tablets? 

  • Take alogliptin and pioglitazone tablets exactly as your doctor tells you to take it.
  • Take alogliptin and pioglitazone tablets 1 time each day with or without food.
  • Do not break or cut alogliptin and pioglitazone tablets before swallowing.
  • Your doctor may need to change your dose of alogliptin and pioglitazone tablets to control your blood glucose. Do not change your dose unless told to do so by your doctor.
  • If you miss a dose, take it as soon as you remember. If you do not remember until it is time for your next dose, skip the missed dose and take the next dose at your regular time.Do nottake 2 doses of alogliptin and pioglitazone tablets at the same time.
  • If you take too many alogliptin and pioglitazone tablets, call your doctor or go to the nearest hospital emergency room right away.
  • If your body is under stress, such as from fever, infection, accident or surgery, the dose of your diabetes medicines may need to be changed. Call your doctor right away.
  • Stay on your diet and exercise programs and check your blood sugar as your doctor tells you to.
  • Your doctor may do certain blood tests before you start alogliptin and pioglitazone tablets and during treatment as needed. Your doctor may change your dose of alogliptin and pioglitazone tablets based on the results of your blood tests due to how well your kidneys are working.
  • Your doctor will check your diabetes with regular blood tests, including your blood sugar levels and your hemoglobin A1C.
  • Your doctor should check your eyes regularly while you take alogliptin and pioglitazone tablets.

Alogliptin And Pioglitazone Tablets Can Cause Serious Side Effects, Including: 

    • Store alogliptin and pioglitazone tablets at room temperature between 68 F to 77 F (20 C to 25 C).
    • Keep container tightly closed and protect from moisture and humidity.

    Keep alogliptin and pioglitazone tablets and all medicines out of the reach of children.

    General information about the safe and effective use of alogliptin and pioglitazone tablets

    Medicines are sometimes prescribed for purposes other than those listed in the Medication Guide. Do not take alogliptin and pioglitazone tablets for a condition for which it was not prescribed. Do not give alogliptin and pioglitazone tablets to other people, even if they have the same symptoms you have. They may harm them.

    This Medication Guide summarizes the most important information about alogliptin and pioglitazone tablets. If you would like to know more information, talk with your doctor. You can ask your doctor or pharmacist for information about alogliptin and pioglitazone tablets that is written for health professionals.

    For more information, go to www.perrigo.com or call 1-877-TAKEDA-7 (1-877-825-3327).

Active Ingredients: 

alogliptin and pioglitazone.

Inactive Ingredients: 

mannitol, microcrystalline cellulose, hydroxypropyl cellulose, croscarmellose sodium, magnesium stearate, and lactose monohydrate; the tablets are film-coated with hypromellose, polyethylene glycol, titanium dioxide, talc and ferric oxide (yellow and/or red) and are marked with red A1 or gray F1 printing ink.

Distributed By
Perrigo
Allegan, MI 49010 www.perrigo.com

All trademarks are the property of their respective owners

ALS333 R5

This Medication Guide has been approved by the U.S. Food and Drug Administration.
12/2016



Your use of this website constitutes your agreement to the terms and conditions linked below:
Terms and Conditions | Resources
2017 © Copyright PharmacyHQ.com. Questions?
Please contact: pharmacyhq.mail@gmail.com